“merck” Archives

in
Entry Author Date Location
PatientSafe Solutions Expands Strategy, Buys Merck’s Vree Health 10/21/15 San Diego
Texas Roundup: RunTitle, BioHouston, Civitas, OncoReponse, DNAtrix 10/06/15 Texas
Houston’s M.D. Anderson, Theraclone Launch Immunotherapy Startup 10/06/15 Texas
Houston Biotech DNAtrix Partners With Merck on Brain Cancer Treatment 10/01/15 Texas
Alector Raises $32M For Immune-Based Neuro Drug Development 09/16/15 San Francisco
Pharma Plays The “Value” Card: Drug Spending Then And Now 09/14/15 National
CureVac Opens up an mRNA Hub in Moderna’s Cambridge Backyard 09/10/15 Boston
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More 09/04/15 Boston
East Coast Biotech Roundup: StartUp Health, Constellation, Highline & More 08/28/15 New York
New CEO and $80M Later, Syndax Looks Prepped for Second IPO Try 08/24/15 Boston
East Coast Biotech Roundup: Editas, Checkmate, Ovid & More 08/14/15 Boston
Moving on From Sarepta, Krieg Lands at Cancer Startup Checkmate Pharma 08/12/15 Boston
Ex-Teva CEO’s Brain Disease Startup, Ovid, Bags $75M From Crossovers 08/11/15 New York
Avitide Gets $7.6M More to Purify Complex Biologics 08/06/15 Boston
With $16M Series B, Antiva Hopes to Kill Cancer-Causing HPV 08/06/15 San Francisco
East Coast Biotech Roundup: Regeneron, Synergy, Foundation & More 07/31/15 Boston
vTv Therapeutics IPO Raises $117M For Alzheimer’s, Diabetes Drugs 07/30/15 Raleigh Durham
Sanofi, Regeneron Set Sights on Immuno-Oncology With New $2B+ Pact 07/28/15 New York
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More 07/24/15 Boston
With $22M Shot of Venture, Sutro Spinout Aims For Better Vaccines 07/23/15 San Francisco
Scynexis Sells CRO Business to Avista, Turns Focus to Antifungal Drug 07/23/15 Raleigh Durham
Ra Pharma Gets $58.5M in Crossover Cash to Target Rare Blood Disease 07/23/15 Boston
RaNA CEO Renaud Turns To A Former Backer To Lead $55M Series B 07/23/15 Boston
25 Years in Biotech 06/22/15 Boston
Flagship CEO on Backing NY Biotech, Moderna, and Investing in a Boom 06/22/15 New York
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More 06/12/15 Boston
Lycera’s End Game? $104M Celgene Deal Could Lead to Buyout 06/11/15 Detroit Ann Arbor
XTuit Gets $22M From NEA, Polaris to Battle Cancer, Liver Disease 06/11/15 Boston
With $30M, Spero Broadens Fight Against Drug-Resistant Bugs 06/08/15 Boston
ASCO Roundup: Checkpoints, Pushback Against Prices, CAR-T & More 06/02/15 National
Page 2 of 19 « previous page · next page »